Figure 6From: Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazineDrug resistance and DNA hypermethylation are reversed with hydralazine. MCF-7/Adr cell viability was evaluated with the MTT assay after treatment with adriamycin and paclitaxel. Cells pretreated with hydralazine had their sensitivity to these drugs restored.Back to article page